Apollomics Inc.

09/16/2024 | Press release | Distributed by Public on 09/16/2024 06:04

Apollomics Presents Vebreltinib Data in Patients with Non-Small Cell Lung Cancer with METex14 Skipping Mutations at European Society for Medical Oncology (ESMO) Congress 2024

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.